Share your story. Make drugs, devices, and vaccines safer.

Boston, Massachusetts
Joined May 2012
New VAERS 2 0 Website and updated vaccine adverse event reporting from @CDCgov & @FDA & bit.ly/VAERS2
1
Higher heart risk seen with Abbott dissolving stent after two years: study whtc.com/news/articles/2017/…
1
MedWatcher retweeted
Why did it take 20 years to learn that a surgical tool used on women could spread cancer? nyti.ms/2kuvGg7
3
29
1
24
MedWatcher retweeted
New paper! Looking for early signals in social media collaborative research with @UMCGlobalSafety @US_FDA @BoozAllen bit.ly/2krnBvS
4
1
Can Twitter & Facebook be used to detect safety signals for medical products? bit.ly/2iVNNLK @DrugSafetyJour
An effective Ebola vaccine - incredible news as we head into 2017! n.pr/2hi1FT3
Chantix, Zyban Lose Boxed Warning on Psych Effects medpagetoday.com/PrimaryCare…
FDA outlines data needed for over-the-counter sunscreen additives fxn.ws/2gezenA
FDA delays experimental arthritis drug, sarilumab, over manufacturing concerns bit.ly/2f6OORO
1
FDA issues new labels for prescription testosterone products bit.ly/2f7zk19
MedWatcher retweeted
3 groundbreaking projects the White House #CancerMoonshot is pursuing bit.ly/2ehlEvY
1
4
Homeopathic teething products could be linked to 10 infant deaths, says FDA bit.ly/2egcCj6
FDA commissioner calls for retraction of Sarepta drug study bit.ly/2dpvTBf @statnews
1
Controversial muscular dystrophy drug approved by FDA nbcnews.to/2ckg8vk
FDA scientists unimpressed by Chantix trial data reut.rs/2c80sLn